Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. | Director | Common Stock | 22.3K | $150K | $6.74 | May 8, 2024 | Direct |
Vigil Neuroscience, Inc. | Director | Stock Option Award (Right to Buy) | 18.1K | $138K | $7.62 | Jun 5, 2024 | Direct |
Mind Medicine (MindMed) Inc. | Director | Common Shares | 19.6K | $71.2K | $3.63 | Jun 21, 2023 | Direct |
PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 26.8K | $55.7K | $2.08 | Jun 13, 2024 | Direct |
Vigil Neuroscience, Inc. | Director | Stock Option Grant (Right to Buy) | 24.1K | Mar 1, 2024 | Direct | ||
Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | May 8, 2024 | Direct | ||
Mind Medicine (MindMed) Inc. | Director | Stock Option (Right to Buy) | 16.5K | Jun 10, 2024 | Direct | ||
Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 5.2K | Sep 30, 2021 | Direct |